Intuitive Surgical, Inc. $ISRG Shares Bought by Vest Financial LLC

Key Points

• Vest Financial LLC increased its stake in Intuitive Surgical by 39.3% during the 2nd quarter, owning a total of 6,585 shares valued at approximately $3.58 million.
• Intuitive Surgical reported a 21.4% increase in revenue year-over-year, reaching $2.44 billion, and achieved an EPS of $2.19 for the quarter, exceeding analyst expectations.
• As of the latest reports, 83.64% of Intuitive Surgical's shares are held by institutional investors, highlighting significant institutional interest in the company.

Vest Financial LLC grew its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 39.3% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,585 shares of the medical equipment provider's stock after acquiring an additional 1,857 shares during the period. Vest Financial LLC's holdings in Intuitive Surgical were worth $3,578,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in ISRG. Brighton Jones LLC boosted its holdings in shares of Intuitive Surgical by 24.9% in the 4th quarter. Brighton Jones LLC now owns 3,672 shares of the medical equipment provider's stock valued at $1,916,000 after buying an additional 731 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Intuitive Surgical by 9.3% in the 1st quarter. GAMMA Investing LLC now owns 6,115 shares of the medical equipment provider's stock valued at $3,029,000 after buying an additional 518 shares during the period. Elevation Point Wealth Partners LLC boosted its holdings in shares of Intuitive Surgical by 16.1% in the 1st quarter. Elevation Point Wealth Partners LLC now owns 562 shares of the medical equipment provider's stock valued at $278,000 after buying an additional 78 shares during the period. Farmers & Merchants Investments Inc. boosted its holdings in shares of Intuitive Surgical by 10.2% in the 1st quarter. Farmers & Merchants Investments Inc. now owns 259 shares of the medical equipment provider's stock valued at $128,000 after buying an additional 24 shares during the period. Finally, Dynamic Advisor Solutions LLC boosted its holdings in shares of Intuitive Surgical by 0.8% in the 1st quarter. Dynamic Advisor Solutions LLC now owns 10,589 shares of the medical equipment provider's stock valued at $5,244,000 after buying an additional 81 shares during the period. 83.64% of the stock is owned by institutional investors and hedge funds.

Intuitive Surgical Trading Up 1.4%

ISRG stock opened at $435.73 on Tuesday. Intuitive Surgical, Inc. has a 52 week low of $425.00 and a 52 week high of $616.00. The company has a market capitalization of $156.20 billion, a price-to-earnings ratio of 60.77, a price-to-earnings-growth ratio of 4.51 and a beta of 1.61. The firm's 50-day moving average is $457.73 and its two-hundred day moving average is $497.44.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 EPS for the quarter, topping analysts' consensus estimates of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The company had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the previous year, the firm earned $1.78 EPS. Intuitive Surgical's revenue was up 21.4% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the sale, the executive vice president directly owned 353 shares in the company, valued at $173,845.44. The trade was a 92.73% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Amy L. Ladd sold 335 shares of the business's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $440.69, for a total transaction of $147,631.15. Following the completion of the sale, the director owned 739 shares in the company, valued at $325,669.91. The trade was a 31.19% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,224 shares of company stock worth $21,716,492. 0.70% of the stock is owned by corporate insiders.

Analyst Ratings Changes

Several research analysts have recently commented on ISRG shares. Deutsche Bank Aktiengesellschaft reaffirmed a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. UBS Group set a $529.00 price target on shares of Intuitive Surgical in a report on Monday. Wells Fargo & Company lifted their price target on shares of Intuitive Surgical from $559.00 to $599.00 and gave the company an "overweight" rating in a report on Wednesday, July 23rd. Zacks Research lowered shares of Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, August 20th. Finally, Royal Bank Of Canada reissued an "outperform" rating and set a $615.00 target price on shares of Intuitive Surgical in a research note on Tuesday, August 19th. Fourteen investment analysts have rated the stock with a Buy rating, seven have issued a Hold rating and one has given a Sell rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $584.76.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.